Skip to main content
. 2019 Mar 4;55(24):3489–3492. doi: 10.1039/c9cc00492k

Scheme 4. Access to pharmacologically active scaffolds. Conditions: (a) HCl, MeOH, RT, 3 h, quantitative yield; (b) 4-Cl-phenoxyacetic acid, CDI, THF:DMF, RT, 60 min then 6p, TEA, DMF, 80 °C, overnight, 38% over two steps.

Scheme 4